These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1719452)

  • 21. Galanin stimulates growth hormone (GH) secretion via GH-releasing factor (GRF) in conscious rats.
    Murakami Y; Kato Y; Koshiyama H; Inoue T; Yanaihara N; Imura H
    Eur J Pharmacol; 1987 Apr; 136(3):415-8. PubMed ID: 2440700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facilitatory role of central dopamine in the osmotic release of vasopressin.
    Yamaguchi K; Hama H
    Brain Res; 1989 Mar; 481(2):388-91. PubMed ID: 2720392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Centrally administered parathyroid hormone (PTH)-related protein(1-34) but not PTH(1-34) stimulates arginine-vasopressin secretion and its messenger ribonucleic acid expression in supraoptic nucleus of the conscious rats.
    Yamamoto S; Morimoto I; Zeki K; Ueta Y; Yamashita H; Kannan H; Eto S
    Endocrinology; 1998 Jan; 139(1):383-8. PubMed ID: 9421437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased motor disturbances in response to arginine vasopressin following hemorrhage or hypertonic saline: evidence for central AVP release in rats.
    Burnard DM; Pittman QJ; Veale WL
    Brain Res; 1983 Aug; 273(1):59-65. PubMed ID: 6616233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiserum against neuropeptide FF augments vasopressin release in conscious rats.
    Yokoi H; Arima H; Kondo K; Murase T; Iwasaki Y; Yang HY; Oiso Y
    Peptides; 1998; 19(2):393-5. PubMed ID: 9493874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galanin-induced prolactin release in rats: pharmacological evidence for the involvement of alpha-adrenergic and opioidergic mechanisms.
    Koshiyama H; Shimatsu A; Kato Y; Assadian H; Hattori N; Ishikawa Y; Tanoh T; Yanaihara N; Imura H
    Brain Res; 1990 Jan; 507(2):321-4. PubMed ID: 1692501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasopressin release within the supraoptic and paraventricular nuclei of the rat brain: osmotic stimulation via microdialysis.
    Landgraf R; Ludwig M
    Brain Res; 1991 Sep; 558(2):191-6. PubMed ID: 1782541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Centrally administered galanin modifies vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of euhydrated and dehydrated rats.
    Ciosek J; Cisowska A
    J Physiol Pharmacol; 2003 Dec; 54(4):625-41. PubMed ID: 14726616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implication of leumorphin in inhibitory control of vasopressin secretion in conscious rats.
    Yamada T; Nakao K; Itoh H; Morii N; Shiono S; Sakamoto M; Sugawara A; Saito Y; Mukoyama M; Arai H
    Hypertension; 1988 Feb; 11(2 Pt 2):I80-3. PubMed ID: 3346067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naloxone disinhibits magnocellular responses to osmotic and volemic stimuli in chronically hypoosmolar rats.
    Dohanics J; Verbalis JG
    J Neuroendocrinol; 1995 Jan; 7(1):57-62. PubMed ID: 7735298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediation of the stress-induced prolactin release by hypothalamic histaminergic neurons and the possible involvement of vasopressin in this response.
    Kjaer A; Knigge U; Olsen L; Vilhardt H; Warberg J
    Endocrinology; 1991 Jan; 128(1):103-10. PubMed ID: 1986913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galanin influences vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of salt loaded rats.
    Cisowska-Maciejewska A; Ciosek J
    J Physiol Pharmacol; 2005 Dec; 56(4):673-88. PubMed ID: 16391423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of naloxone on vasopressin secretion in conscious rats: evidence for inhibitory role of endogenous opioid peptides in vasopressin secretion.
    Yamada T; Nakao K; Itoh H; Shirakami G; Sugawara A; Saito Y; Mukoyama M; Arai H; Hosoda K; Shiono S
    Endocrinology; 1989 Aug; 125(2):785-90. PubMed ID: 2546748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative biological activities of alpha-rat and alpha-human atrial natriuretic peptide in the inhibition of arginine vasopressin release in conscious rats.
    Kaneko K; Fukuda S; Ishikawa S; Saito T
    Endocrinol Jpn; 1988 Dec; 35(6):809-17. PubMed ID: 2855064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracerebroventricular injection of brain natriuretic peptide inhibits vasopressin secretion in conscious rats.
    Yamada T; Nakao K; Itoh H; Shirakami G; Kangawa K; Minamino N; Matsuo H; Imura H
    Neurosci Lett; 1988 Dec; 95(1-3):223-8. PubMed ID: 3226610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the release of vasopressin within the supraoptic nucleus of the rat brain depend upon changes in osmolality and Ca2+/K+?
    Ludwig M; Landgraf R
    Brain Res; 1992 Apr; 576(2):231-4. PubMed ID: 1515919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrin-releasing peptide stimulation of corticotropin secretion in male rats.
    Olsen L; Knigge U; Warberg J
    Endocrinology; 1992 May; 130(5):2710-6. PubMed ID: 1315254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of centrally administered ET-1-induced increases in systemic arterial pressure and AVP secretion.
    Rossi NF; O'Leary DS; Chen H
    Am J Physiol; 1997 Jan; 272(1 Pt 1):E126-32. PubMed ID: 9038861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential contribution of angiotensinergic and cholinergic receptors in the hypothalamic paraventricular nucleus to osmotically induced AVP release.
    Qadri F; Waldmann T; Wolf A; Höhle S; Rascher W; Unger T
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1012-8. PubMed ID: 9618402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.